- Home
- SOPH
SOPH
SOPHiA GENETICS SA
as 06-23-2025 4:00pm EST
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
| Founded: | 2011 | Country: | Switzerland |
| Employees: | N/A | City: | N/A |
| Market Cap: | 193.8M | IPO Year: | 2021 |
| Target Price: | $6.50 | AVG Volume (30 days): | 163.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.00 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.58 - $4.92 | Next Earning Date: | 08-05-2025 |
| Revenue: | $67,173,000 | Revenue Growth: | 4.66% |
| Revenue Growth (this year): | 16.07% | Revenue Growth (next year): | 22.94% |
Latest SOPHiA GENETICS SA News
SOPH Breaking Stock News: Dive into SOPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
18 hours ago
June 2025's Promising Penny Stocks With Growth Potential
Simply Wall St.
a month ago
SOPHiA GENETICS First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
2 months ago
Sophia Genetics SA (SOPH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Improved ...
Zacks
2 months ago
SOPHiA GENETICS SA (SOPH) Reports Q1 Loss, Tops Revenue Estimates
PR Newswire
2 months ago
SOPHiA GENETICS Reports First Quarter 2025 Results
GuruFocus.com
2 months ago
Earnings To Watch: Sophia Genetics SA (SOPH) Reports Q1 2025 Result
Simply Wall St.
2 months ago
Promising Penny Stocks To Consider In April 2025
MT Newswires
2 months ago
SOPHiA, AstraZeneca Expand Deployment of Liquid Biopsy Testing
Compare SOPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOPH SOPHiA GENETICS SA - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.